This page shows the latest Ruud Dobber news and features for those working in and with pharma, biotech and healthcare.
This agreement supports the management of our mature medicines to enable reinvestment into the pipeline and bringing new, innovative treatments to patients,” said Ruud Dobber, executive vice president, BioPharmaceuticals Business Unit,
This divestment supports our strategy of reducing the number of mature medicines to enable reinvestment in our main therapy areas,” said Ruud Dobber, executive vice president, BioPharmaceutical Business Unit at AZ.
attack or stroke,” said Ruud Dobber, executive vice president of biopharmaceuticals at AZ.
with high unmet medical need,” said Ruud Dobber, executive vice president of BioPharmaceuticals at AZ.
Dave Fredrickson retains his position as head of the global oncology business unit, and Ruud Dobber – formerly AZ’s head of North American commercial operations – will take over the running of
L-R: Ruud Dobber and Mene Pangalos. Speculation about potential successors name Mene Pangalos, AZ’s British-born head of the IMED Biotech Unit and business development chief, and Ruud Dobber,
More from news
Approximately 1 fully matching, plus 7 partially matching documents found.
OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...